PEGylated cationic liposomal-oxaliplatin display impressive anticancer efficacy by dual-targeting of immunosuppressive populations and cancer-cells

Lars Petersen, Lars Ringgaard, Fredrik Melander, Ragnhild Garborg Østrem, Kasper Kristensen, Jonas Henriksen, Dennis Elema, Andreas Kjær, Thomas Andresen

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberP656
JournalJournal for ImmunoTherapy of Cancer
Volume7
Issue numberSuppl. 1
ISSN2051-1426
Publication statusPublished - 2019
Event34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) - Gaylord National Hotel & Convention Center, National Harbour, United States
Duration: 6 Nov 201910 Nov 2019
https://www.sitcancer.org/2019/home

Conference

Conference34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019)
LocationGaylord National Hotel & Convention Center
CountryUnited States
CityNational Harbour
Period06/11/201910/11/2019
Internet address

Cite this

@article{35da08cf116b4fe98b5b50fc70f07ddb,
title = "PEGylated cationic liposomal-oxaliplatin display impressive anticancer efficacy by dual-targeting of immunosuppressive populations and cancer-cells",
author = "Lars Petersen and Lars Ringgaard and Fredrik Melander and {\O}strem, {Ragnhild Garborg} and Kasper Kristensen and Jonas Henriksen and Dennis Elema and Andreas Kj{\ae}r and Thomas Andresen",
year = "2019",
language = "English",
volume = "7",
journal = "Journal for ImmunoTherapy of Cancer",
issn = "2051-1426",
publisher = "BioMed Central Ltd.",
number = "Suppl. 1",

}

PEGylated cationic liposomal-oxaliplatin display impressive anticancer efficacy by dual-targeting of immunosuppressive populations and cancer-cells. / Petersen, Lars; Ringgaard, Lars; Melander, Fredrik; Østrem, Ragnhild Garborg; Kristensen, Kasper; Henriksen, Jonas ; Elema, Dennis ; Kjær, Andreas ; Andresen, Thomas .

In: Journal for ImmunoTherapy of Cancer, Vol. 7, No. Suppl. 1, P656, 2019.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

TY - ABST

T1 - PEGylated cationic liposomal-oxaliplatin display impressive anticancer efficacy by dual-targeting of immunosuppressive populations and cancer-cells

AU - Petersen, Lars

AU - Ringgaard, Lars

AU - Melander, Fredrik

AU - Østrem, Ragnhild Garborg

AU - Kristensen, Kasper

AU - Henriksen, Jonas

AU - Elema, Dennis

AU - Kjær, Andreas

AU - Andresen, Thomas

PY - 2019

Y1 - 2019

M3 - Conference abstract in journal

VL - 7

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

SN - 2051-1426

IS - Suppl. 1

M1 - P656

ER -